Educational Follow-up in a Cohort of Children at the Royal Marsden Hospital (RMH)

Brain Tumour Clinical Trial

Official title:

Educational Follow-up in a Cohort of Children at the Royal Marsden Hospital, Following the Treatment of a Brain Tumour

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00996450
• Other study ID #: CCR2903
• Status: Completed
• Phase: N/A
• First received: October 15, 2009
• Last updated: May 20, 2016
• Start date: June 2008
• Est. completion date: December 2009

Study information

• Verified date: October 2009
• Source: Royal Marsden NHS Foundation Trust
• Contact: n/a
• Is FDA regulated: No
• Health authority: United Kingdom: Research Ethics Committee
• Study type: Observational

Clinical Trial Summary

To document pre-diagnosis educational abilities, to document any change in educational achievements following treatment, to document educational support given within the statement process and to document the timing of support.

Description:

This will be a retrospective study. Cases will be identified by looking at the Royal Marsden Hospital (RMH) coding database. All the patients will have completed treatment for a brain tumour. The children all need to have started school before the diagnosis of their brain tumour so that we can look at easily defined educational assessments in this cohort. Children will be identified by looking at RMH coding of diagnosis and include children aged between 4 years and 18 years old (school age).

Recruitment information / eligibility

• Status: Completed
• Enrollment: 110
• Est. completion date: December 2009
• Est. primary completion date: December 2009
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 4 Years to 18 Years

Eligibility

Inclusion Criteria:

• patients/parental consent for RMH accessing educational information from them and their school

• patients with a primary brain tumour

Exclusion Criteria:

• children with secondary brain tumours

• children who have had treatment for a relapse of primary brain tumour

Study Design

Observational Model: Family-Based, Time Perspective: Retrospective

Related Conditions & MeSH terms

• Brain Neoplasms
• Brain Tumour

Locations

Country	Name	City	State
United Kingdom	The Royal Marsden NHS Foundation Trust	Belmont	Surrey

Sponsors (1)

Lead Sponsor	Collaborator
Royal Marsden NHS Foundation Trust

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Secondary	To compare educational achievements of children of different tumour types following treatment.			No
Secondary	To document if there are any differences in educational achievements depending on the age at diagnosis of the brain tumour.			No